Minerva Neurosciences, Inc. (NERV)
4.17
+0.05
(+1.21%)
USD |
NASDAQ |
Sep 10, 16:00
4.17
0.00 (0.00%)
After-Hours: 19:17
Minerva Neurosciences Total Liabilities (Quarterly) : 308.39M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 308.39M |
| March 31, 2026 | 348.04M |
| December 31, 2025 | 238.72M |
| September 30, 2025 | 62.67M |
| June 30, 2025 | 62.53M |
| March 31, 2025 | 61.95M |
| December 31, 2024 | 62.84M |
| September 30, 2024 | 64.48M |
| June 30, 2024 | 90.78M |
| March 31, 2024 | 87.10M |
| December 31, 2023 | 85.36M |
| September 30, 2023 | 83.18M |
| June 30, 2023 | 79.65M |
| March 31, 2023 | 78.21M |
| December 31, 2022 | 75.11M |
| September 30, 2022 | 74.00M |
| June 30, 2022 | 73.34M |
| March 31, 2022 | 71.35M |
| December 31, 2021 | 69.15M |
| September 30, 2021 | 69.48M |
| June 30, 2021 | 69.16M |
| March 31, 2021 | 66.46M |
| December 31, 2020 | 7.314M |
| September 30, 2020 | 7.198M |
| June 30, 2020 | 9.223M |
| Date | Value |
|---|---|
| March 31, 2020 | 50.16M |
| December 31, 2019 | 52.07M |
| September 30, 2019 | 55.29M |
| June 30, 2019 | 53.02M |
| March 31, 2019 | 52.38M |
| December 31, 2018 | 54.16M |
| September 30, 2018 | 49.13M |
| June 30, 2018 | 50.28M |
| March 31, 2018 | 53.18M |
| December 31, 2017 | 57.39M |
| September 30, 2017 | 63.33M |
| June 30, 2017 | 29.35M |
| March 31, 2017 | 29.02M |
| December 31, 2016 | 26.96M |
| September 30, 2016 | 28.58M |
| June 30, 2016 | 25.90M |
| March 31, 2016 | 27.78M |
| December 31, 2015 | 27.26M |
| September 30, 2015 | 26.25M |
| June 30, 2015 | 25.95M |
| March 31, 2015 | 27.41M |
| December 31, 2014 | 16.95M |
| September 30, 2014 | 16.61M |
| June 30, 2014 | 23.72M |
| March 31, 2014 | 19.05M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 95.09M |
| Shareholders Equity (Quarterly) | -213.30M |
| Debt to Equity Ratio | -0.3363 |
| Current Ratio | 20.14 |
| Net Debt Paydown Yield | -0.90% |